Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ocugen, Inc.

Ocugen, Inc. (OCGN) Stock Overview

Explore Ocugen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

OCGN●NASDAQ
HealthcareBiotechnology
$1.39
$0.00(0.00%)
U.S. Market opens in 54h 38m

Ocugen, Inc. (OCGN)

Meyka AI Score

Z

Key Financials

Market Cap471.4M
P/E Ratio-5.47
EPS (TTM)$-0.26
ROE16.88%
Fundamental Analysis

AI Price Forecasts

1 Month$1.47
3 Months$1.36
1 Year Target$1.47

OCGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Ocugen, Inc. (NASDAQ: OCGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ocugen, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OCGN on the NASDAQ shows an RSI of 53.00, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.47 for the NASDAQ listing.

Key metrics behind Ocugen, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.47 and a market capitalization of 471.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OCGN on the NASDAQ.

Price Performance (NASDAQ: OCGN)

1-Day Change
N/A
5-Day Change
2.21%
1-Month Change
6.92%
3-Month Change
2.96%
6-Month Change
-13.13%
Year-to-Date (YTD) Change
2.96%
1-Year Change
37.62%
3-Year Change
213.77%
5-Year Change
-81.83%
All-Time (Max) Change
-99.80%

Contact Information

https://www.ocugen.com
484 328 4701
263 Great Valley Parkway, Malvern, PA, 19355

Company Facts

1,160 Employees
IPO DateDec 3, 2014
CountryUS
Actively Trading

Frequently Asked Questions